Founded in 2019 by the venture capital firm Forbion and John Kastelein, NewAmsterdam Pharma is a privately held, clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies are not tolerated or have been unsuccessful.

Biotechnology

New Amsterdam Pharma

New Amsterdam Pharma's headquarters in Naarden, Netherlands

Michael Davidson

Douglas Kling

Marc Ditmarsch

M. Ian Somaiya

BJ Jones

Matthew Philippe

David Topper

John Kastelein

Wouter Joustra

Nicholas Downing

Sander Van Slootweg

Lou Lange

James N. Topper

Juliette Audet

John Smither

Stephen Nicholls

Ann Marie Navar

Christie Ballantyne

Kosh Ray

Brian Ference

Janneke van der Kamp

The Board and Advisory Team at New Amsterdam Pharma is responsible for guiding the company's strategic direction, overseeing key business decisions, and ensuring successful clinical research and development of cardiometabolic therapies. Composed of board members and clinical advisors, this team provides expert advice, governance, and industry insights to help achieve the company's mission of improving patient care where traditional treatments fall short.

Board and Advisory Team

The Executive Management Team at New Amsterdam Pharma is responsible for setting the strategic vision and overall direction of the company. This includes making high-level decisions on business operations, guiding research and development initiatives, securing funding, ensuring regulatory compliance, and overseeing the commercial strategy to bring transformative cardiometabolic therapies to market. This team works collaboratively to drive organizational growth and ensure operational excellence while adhering to the company's mission of improving patient care.

Executive Management Team

The Finance Team at NewAmsterdam Pharma manages the company’s financial planning and analysis, budgets, and financial reporting. They support the clinical-stage research and development efforts by ensuring financial efficiency, compliance, and strategic allocation of resources to advance the company's mission of developing innovative cardiometabolic therapies. The team also collaborates closely with other departments to guide financial decisions and foster sustainable growth.

Finance Team

The Clinical Operations team at New Amsterdam Pharma oversees the planning, execution, and management of clinical trials to ensure they are conducted efficiently and in compliance with regulatory requirements. The team collaborates closely with internal and external stakeholders to advance the development of new therapies for cardiometabolic diseases, aiming to bring innovative treatment options to patients.

Clinical Operations

The Leadership Team at New Amsterdam Pharma is responsible for setting the strategic direction and overseeing the operations of the company. Comprised of executive leaders such as the CEO, CFO, and CSO, the team collaborates to drive innovation in the research and development of therapies for cardiometabolic diseases, ensuring alignment with the company's mission to enhance patient care and address unmet needs in the healthcare landscape.

Leadership Team

New Amsterdam Pharma

Org chart

Board & advisors

Teams

Board and Advisory Team

Executive Management Team

Finance Team

Clinical Operations

Leadership Team

Offices

New Amsterdam Pharma

Org chart

Board & advisors

Teams

Board and Advisory Team

Executive Management Team

Finance Team

Clinical Operations

Leadership Team

Offices

Related companies